Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Methyldopa

2

XII.d Myocarditis (can be fulminant)

1
Last update : 30/08/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

Myocarditis and methyldopa.
Acta medica Scandinavica 1982 May;211;233-5 1982 May
Fatal methyldopa-associated granulomatous hepatitis and myocarditis.
The American journal of the medical sciences 1982;283;41-5 1982
Drug related myocarditis. I. Hypersensitivity myocarditis.
Human pathology 1981 Oct;12;900-7 1981 Oct
Myocarditis associated with methyldopa therapy.
JAMA 1977 Apr 18;237;1699-701 1977 Apr 18

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies